WASHINGTON, Feb. 5 -- Sen. Tommy Tuberville issued the following press release:
Today, U.S. Senator Tommy Tuberville (R-AL) and Oxford Pharmaceuticals Chairman Tom Neely penned an op-ed in Yellowhammer News outlining the importance of returning generic drug production to America instead of relying on foreign supply chains.
Excerpts from the op-ed can be found below, and the full op-ed can be read here.
"While many of us try our best to forget the COVID pandemic in 2020, one serious issue that was revealed during that chaotic time is still impacting us today-our reliance on other countries for medications. Most Americans are so used to taking medicines that they don't stop to think where the medicine in their cabinets is coming from. The ...